Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Glucose and Metformin

supplement:

Glucose

Research Papers that Mention the Interaction

Fasting glucose , glycated hemoglobin, and HOMA1‐IR were lower after than before metformin treatment.
Fundamental & clinical pharmacology  •  2020  |  View Paper
The effects of metformin can be enhanced by nutrient deprivation (ie, glucose , amino acids), which reduces intracellular levels of ATP and anabolic precursors and can be achieved by the fasting mimicking diet (FMD).
Clinical lung cancer  •  2019  |  View Paper
Consequently, increased colonic glucose use might partly explain the weight losing effect of metformin when this results in an increased energy expenditure and/or core body temperature.
PloS one  •  2017  |  View Paper
BACKGROUND Metformin may improve metabolic factors (insulin, glucose , leptin, highly sensitive C-reactive protein [hs-CRP]) associated with poor breast cancer outcomes.
Journal of the National Cancer Institute  •  2015  |  View Paper
metformin 1000 mg group had … significantly greater decline in glucose and HbA1c levels between treatment weeks 0 and 6 month (p = 0.008 and 0.009, respectively), and the declines … with an increase in body mass index (BMI) level (p interaction with BMI = 0.007 and 0.067, respectively).
Breast Cancer Research and Treatment  •  2015  |  View Paper
In addition, metformin induced an improvement of endocrine and anthropometric parameters in PCOS subjects by reducing glucose , follicle-stimulating hormone (FSH) and androstendione, and by increasing dehydroepiandrosterone-sulfate (DHEA-S).
Atherosclerosis  •  2015  |  View Paper
Metformin treatment, in addition to life style intervention, significantly reduced morning glucose and HbA1c whilst body weight and BMI were only marginally reduced during the 24 week trial.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association  •  2014  |  View Paper
The molecular mechanisms of metformin have not been fully identified, but turnover of biomarkers such as glucose and signalling pathways or translocation of glucose transporters are closely related to the glucose-lowering effects of metformin.
British journal of clinical pharmacology  •  2012  |  View Paper
Results:Patients receiving metformin had a significant decrease in their plasma glucose concentration, the rate of glucose production , and an increase in glucose clearance.
Annals of surgery  •  2005  |  View Paper
Show More